Evaluation of Rovadicitinib Compared to the Protocol Selected by Researchers in Third Line and Subsequent Studies of Moderate to Severe Chronic Graft-versus-host Disease

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Evaluation of Rovadicitinib Compared to the Protocol Selected by Researchers in Third Line and Subsequent Studies of Moderate to Severe Chronic Graft-versus-host Disease	graft versus host disease, immune system disorder	Recruiting	Phase 3	2025-12-08		NCT06682169

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.	88

41 results · Page 1 of 2

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Chinese Academy of Medical Sciences Hematology Hospital	Tianjin	China	1
First Hospital of Jilin University	Changchun	China	1
Fujian Medical University Union Hospital	Fuzhou	China	107
Guangzhou First People's Hospital The First People's Hospital Affiliated to Guangzhou Medical University	Guangzhou	China	1
Henan Cancer Hospital	Zhenzhou	China	2
Henan Provincial People's Hospital	Zhengzhou	China	45
Huai'an Second People's Hospital	Huai'an	China	1
Jiangsu Province Hospital	Nanjing	China	89
Nanfang Hospital	Guangzhou	China	17
Peking University First Hospital	Beijing	China	163
Peking University People's Hospital	Beijing	China	146
Qilu Hospital of Shandong University	Jinan	China	138
Ruijin Hospital, Shanghai Jiaotong University School of Medicine	Shanghai	China	45
Shanghai Jiao Tong University School of Medicine，Renji Hospital	Shanghai	China	2
Shanxi Bethune Hospital	Taiyuan	China	26
Shanxi Provincial People's Hospital	Xi’an	China	1
Sichuan Provincial People's Hospital	Chengdu	China	50
Tai'an City Central Hospital	Tai’an	China	1
The 904 Hospital of the Joint Service Support Force of the People's Liberation Army of China	Lanzhou	China	1
The Affiliated Hospital of Guizhou Medical University	Guiyang	China	5
The Affiliated People's Hospital of Ningbo University	Ningbo	China	3
The First Affiliated Hospital of Guangxi Medical University	Nanning	China	66
The First Affiliated Hospital of Nanchang University	Nanchang	China	109
The First Affiliated Hospital of Ningbo University	Ningbo	China	2
The First Affiliated Hospital of USTC Anhui Provincial Hospital	Hefei	China	7

Evaluation of Rovadicitinib Compared to the Protocol Selected by Researchers in Third Line and Subsequent Studies of Moderate to Severe Chronic Graft-versus-host Disease

Evaluation of Rovadicitinib Compared to the Protocol Selected by Researchers in Third Line and Subsequent Studies of Moderate to Severe Chronic Graft-versus-host Disease

Clinical trials

Organizations

Research sites